Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What financing options are available to support the start-up and operation of a pharmaceutical business? Are bank loans difficult to obtain?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q271 · Category F: Fees, Budget and Financial Planning (Q251-Q300)
There are several ways to finance your pharmaceutical business: 1. “Personal funds and investment from family and friends”: this is the most common way to get started, but roles and responsibilities should be clearly defined. 2. “Commercial bank loans”: you can apply to a bank for an SME loan or commercial loan. 3. “Government funding schemes”: the Hong Kong Government offers various funding schemes for technology and SMEs, some of which may be relevant to your business. 4. “Private equity or venture capital”: if your project is distinctive and has high growth potential, it may attract professional investors. Bank loans are relatively difficult to obtain because the pharmaceutical industry is specialised and heavily regulated, so banks are very cautious when assessing applications. They will need to see a highly professional and detailed business plan, as well as evidence that your team has the expertise to operate the business.

📘 Regulatory basis

When assessing a loan application, banks may indirectly refer to the Department of Health’s licensing guidelines. They need to ensure that your business model is based on lawful and compliant operations; otherwise, the lending risk is too high.

📗 Drew Tang's recommendations

A business plan prepared with assistance from professional consultants such as us at RGYS: RGYS may assist with document preparation and project coordination within the written scope of services; the respective responsible parties must verify personnel qualifications and statutory roles and take responsibility for professional judgements, while approval is determined independently by the competent authority. The plan should include not only clear profit forecasts but also a complete set of compliant operating arrangements and risk-control measures, demonstrating your professionalism and reliability to banks.

📕 Risk notice

The greatest risks when seeking external financing are giving away too much equity or accepting debt with onerous terms. When negotiating with investors or banks, always seek independent legal and financial advice to protect your long-term interests. Do not put yourself in a worse position by taking desperate measures to obtain funding.

Back to Category F: Fees, Budget and Financial Planning (Q251-Q300) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗